MicroRNA dysregulations in Merkel cell carcinoma: molecular mechanisms and clinical application - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Journal of Medical Virology Année : 2023

MicroRNA dysregulations in Merkel cell carcinoma: molecular mechanisms and clinical application

Résumé

Merkel cell carcinoma (MCC) is an aggressive skin malignancy with two distinct etiologies. The first, which accounts for the highest proportion, is caused by Merkel cell polyomavirus (MCPyV), a DNA tumor virus. A second, UV-induced, MCC form has also been identified. Few MCC diagnostic, prognostic and therapeutic options are available. MicroRNAs (miRNAs) are small non-coding RNA molecules, which play a key role in regulating various physiologic cellular functions including cell cycling, proliferation, differentiation, and apoptosis. Numerous miRNAs are dysregulated in cancer, by acting as either tumor suppressors or oncomiRs. The aim of this review is to collect, summarize and discuss recent findings on miRNAs whose dysregulation has been assumed to play a role in MCC. The potential clinical application of miRNAs as diagnostic and prognostic biomarkers in MCC is also described. In the future, miRNAs will potentially gain clinical significance for the improvement of MCC diagnostic, prognostic and therapeutic options. This article is protected by copyright. All rights reserved.

Domaines

Cancer
Fichier non déposé

Dates et versions

hal-03900695 , version 1 (15-12-2022)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

Chiara Mazziotta, Christian Felice Cervellera, Carmen Lanzillotti, Antoine Touzé, Pauline Gaboriaud, et al.. MicroRNA dysregulations in Merkel cell carcinoma: molecular mechanisms and clinical application. Journal of Medical Virology, 2023, 95 (1), pp.e28375. ⟨10.1002/jmv.28375⟩. ⟨hal-03900695⟩
20 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More